Literature DB >> 2892806

Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study.

L Juhlin1, J R Gibson, S G Harvey, L W Huson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2892806     DOI： 10.1111/j.1365-4362.1987.tb02275.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

1.  Treatment of itching in atopic eczema with antihistamines with a low sedative profile.

Authors:  V Doherty; D G Sylvester; C T Kennedy; S G Harvey; J G Calthrop; J R Gibson
Journal:  BMJ       Date:  1989-01-14

Review 2.  The antihistamines of the nineties.

Authors:  M M Janssens; P H Howarth
Journal:  Clin Rev Allergy       Date:  1993

Review 3.  Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.

Authors:  R N Brogden; D McTavish
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 4.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.